Synthesis, NMR Spectroscopy, and Molecular Modeling of 2-Methyl-2,3,4,5-tetrahydro-1H-[1]benzothieno[2,3-c]azepine

被引:1
作者
Eresko, A. B. [1 ]
Raksha, E. V. [1 ]
Berestneva, Yu. V. [2 ]
Muratov, A. V. [1 ]
Voitash, A. A. [1 ]
Tolkunov, V. S. [3 ]
Tolkunov, S. V. [3 ]
机构
[1] Litvinenko Inst Phys Organ & Coal Chem, UA-83114 Donetsk, Ukraine
[2] Russian Acad Sci, Fed Res Ctr Agroecol Complex Meliorat & Protect A, Volgograd 400062, Russia
[3] Natl Acad Sci Ukraine, Litvinenko Inst Phys Organ & Coal Chem, UA-02160 Kiev, Ukraine
关键词
fused azepines; Eschweiler-Clark reaction; chemical shift; coalescence; inversion barrier; GIAO; INVERSION;
D O I
10.1134/S1070428020110068
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new synthetic approach to fused azepines was demonstrated on an example of the synthesis of 2-methyl-2,3,4,5-tetrahydro-H-1-[1]benzothieno[2,3-c]azepine. The key stage of the synthesis is the formation of the azepine ring under the Eschweiler-Clark reaction conditions. The Gibbs energy of activation for the inversion of the azepine ring was determined by dynamic H-1 NMR spectroscopy. Molecular modeling of the structure and estimation of the H-1 and C-13 NMR chemical shifts were performed for 2-methyl-2,3,4,5-tetrahydro-1H-[1]benzothieno[2,3-c]azepine. The magnetic shielding tensors were calculated by the standard GIAO method using the B3LYP/6-31G(d,p)-optimized molecular geometry parameters. The solvent effect was taken into account in the PCM approximation. The calculated H-1 and C-13 NMR chemical shifts of 2-methyl-2,3,4,5-tetrahydro-1H-[1]benzothieno[2,3-c]azepine are in good agreement with the experimental values observed in the spectra of its DMSO-d(6) solution.
引用
收藏
页码:1929 / 1936
页数:8
相关论文
共 25 条
[1]   Benzothiophene inhibitors of MK2. Part 1: Structure-activity relationships, assessments of selectivity and cellular potency [J].
Anderson, David R. ;
Meyers, Marvin J. ;
Kurumbail, Ravi G. ;
Caspers, Nicole ;
Poda, Gennadiy I. ;
Long, Scott A. ;
Pierce, Betsy S. ;
Mahoney, Matthew W. ;
Mourey, Robert J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) :4878-4881
[2]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[3]   Modeling of NMR spectra and signal assignment using real-time DFT/GIAO calculations [J].
Belaykov, P. A. ;
Ananikov, V. P. .
RUSSIAN CHEMICAL BULLETIN, 2011, 60 (05) :783-789
[4]   Preparation of 3-aminoalkylbenzo[b]thiophenes [J].
Burkamp, F ;
Fletcher, SR .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2002, 39 (06) :1177-1187
[5]   Synthesis and Anticancer Activity of 2-Aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-Aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones [J].
Chaban, T., I ;
Matiichuk, Y. E. ;
Horishny, V. Ya ;
Chaban, I. G. ;
Matiychuk, V. S. .
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 56 (05) :813-818
[6]   Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists [J].
Espahbodinia, Milad ;
Ettari, Roberta ;
Wen, Wei ;
Wu, Andrew ;
Shen, Yu-Chuan ;
Niu, Li ;
Grasso, Silvana ;
Zappala, Maria .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) :3631-3637
[7]   A Review of 2,3-Benzodiazepine-related Compounds: Diazepines and 1,2,5-Triazepines Fused with Five-membered Nitrogen Heterocycles [J].
Foldesi, Tamas ;
Volk, Balazs ;
Milen, Matyas .
CURRENT ORGANIC SYNTHESIS, 2018, 15 (06) :729-754
[8]  
Frisch M.J., 2010, Gaussian 09
[9]   Synthesis and anticonvulsant activity of novel and potent 1-aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-ones [J].
Grasso, S ;
De Sarro, G ;
De Sarro, A ;
Micale, N ;
Polimeni, S ;
Zappalà, M ;
Puia, G ;
Baraldi, M ;
De Micheli, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) :463-466
[10]   Phase 2 Trial of Talampanel, a Glutamate Receptor Inhibitor, for Adults With Recurrent Malignant Gliomas [J].
Iwamoto, Fabio M. ;
Kreisl, Teri N. ;
Kim, Lyndon ;
Duic, J. Paul ;
Butman, John A. ;
Albert, Paul S. ;
Fine, Howard A. .
CANCER, 2010, 116 (07) :1776-1782